Other
Gross Unrealized Gains
Biogen Gross Unrealized Gains decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Gross Unrealized Gains shows a downward trend with a -55.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ4 2021
Last reportedQ1 2026
How to read this metric
An increase indicates favorable market conditions for the fixed-income portfolio, potentially boosting book value.
Detailed definition
The total amount of unrealized gains on debt securities classified as available-for-sale that have not yet been recogniz...
Peer comparison
Standard metric for insurance companies holding large bond portfolios.
Metric ID:
other_available_for_sale_debt_securities_accumulated_gro_8d5dbcHistorical Data
12 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.40M | $1.10M | $400.00K | $1.40M | $400.00K | $100.00K | $300.00K | $2.30M | $1.10M | $0.00 | $200.00K | $0.00 |
| QoQ Change | — | -21.4% | -63.6% | +250.0% | -71.4% | -75.0% | +200.0% | +666.7% | -52.2% | -100.0% | — | -100.0% |
| YoY Change | — | — | — | — | -71.4% | -90.9% | -25.0% | +64.3% | +175.0% | — | — | — |
Range$0.00 – $2.30M
CAGR-100.0%
Avg YoY Growth+10.4%
Median YoY Growth-25.0%
Gross Unrealized Gains at Other Companies
Frequently Asked Questions
- What is Biogen's gross unrealized gains?
- Biogen (BIIB) reported gross unrealized gains of $0.00 in Q1 2026.
- What is the long-term trend for Biogen's gross unrealized gains?
- Over 3 years (2020 to 2025), Biogen's gross unrealized gains has grown at a -55.7% compound annual growth rate (CAGR), from $2.30M to $200.00K.
- What does gross unrealized gains mean?
- The total paper profit on debt investments that have not been sold yet.